Stay updated on Duvelisib in Refractory Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib in Refractory Lymphoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Updated the study locations section to include detailed site locations by state/province and country (including Minsk Oblast, Ontario, and Quebec) and updated the revision to v3.3.3.
    Difference
    2%
    Check dated 2025-12-17T20:20:59.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A note was added clarifying that PubMed publications are automatically populated and may not all relate to the study, and the revision label was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T13:50:11.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Notice about government funding status and NIH operating status has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-19T08:32:44.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No substantive changes were detected in the Study Details page for NCT01882803; the core sections including eligibility criteria, primary outcomes, and locations appear unchanged between the screenshots.
    Difference
    0.3%
    Check dated 2025-10-28T05:17:33.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    4%
    Check dated 2025-10-06T16:03:40.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    Update: citation updated from v3.0.2 to v3.1.0 and addition of an erratum note; essentially a bibliographic metadata precision upgrade rather than a major content change.
    Difference
    0.5%
    Check dated 2025-09-29T09:58:37.000Z thumbnail image

Stay in the know with updates to Duvelisib in Refractory Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.